Ascendis Pharma A/S Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 11/14/2025 | 10.28 M | $2.04 B | 0.00% | 17.01% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 11/12/2025 | 5.26 M | $1.05 B | -3.51% | 8.70% |
| AVORO CAPITAL ADVISORS LLC | 11/14/2025 | 5.11 M | $1.02 B | 2.61% | 8.45% |
| FMR LLC | 11/13/2025 | 4.47 M | $889.03 M | -1.32% | 7.40% |
| JANUS HENDERSON GROUP PLC | 11/14/2025 | 4.32 M | $859.42 M | -2.37% | 7.15% |
| LOMBARD ODIER ASSET MANAGEMENT (EUROPE) LTD | 11/14/2025 | 4.27 M | $5.83 M | 100.00% | 7.06% |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 11/12/2025 | 3.72 M | $739.75 M | -6.75% | 6.15% |
| CAPITAL INTERNATIONAL INVESTORS | 11/13/2025 | 3.06 M | $608.48 M | 0.45% | 5.06% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 11/14/2025 | 2.67 M | $530.15 M | -25.59% | 4.41% |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 10/29/2025 | 1.88 M | $374.32 M | -1.00% | 3.11% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 1.80 M | $357.65 M | 95.94% | 2.98% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2025 | 1.73 M | $343.19 M | -7.96% | 2.86% |
| FRANKLIN RESOURCES INC | 11/13/2025 | 1.59 M | $316.10 M | -9.33% | 2.63% |
| PERCEPTIVE ADVISORS LLC | 11/14/2025 | 1.09 M | $216.40 M | 12.93% | 1.80% |
| INVESCO LTD. | 11/13/2025 | 917.90 K | $182.49 M | -3.10% | 1.52% |
| POLAR CAPITAL HOLDINGS PLC | 11/14/2025 | 857.91 K | $170.56 M | 2.40% | 1.42% |
| PRINCIPAL FINANCIAL GROUP INC | 11/04/2025 | 793.68 K | $157.79 M | 2,722.87% | 1.31% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 653.01 K | $129.83 M | 21.31% | 1.08% |
| VESTAL POINT CAPITAL, LP | 11/14/2025 | 600.00 K | $119.29 M | 200.00% | 0.99% |
| AMERIPRISE FINANCIAL INC | 11/14/2025 | 562.94 K | $111.92 M | -4.27% | 0.93% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2025 | 544.61 K | $108.27 M | 2.60% | 0.90% |
| FIL LTD | 11/13/2025 | 459.34 K | $91.32 M | -1.02% | 0.76% |
| BLACKROCK, INC. | 11/12/2025 | 451.50 K | $89.76 M | -4.29% | 0.75% |
| MORGAN STANLEY | 11/14/2025 | 406.76 K | $80.87 M | 59.65% | 0.67% |
| GROUPAMA ASSET MANAGMENT | 12/01/2025 | 400.00 K | $534.74 K | 0.00% | 0.66% |
| SPYGLASS CAPITAL MANAGEMENT LLC | 11/14/2025 | 388.65 K | $77.27 M | 100.00% | 0.64% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2025 | 375.90 K | $74.73 M | -0.48% | 0.62% |
| MACQUARIE GROUP LTD | 11/13/2025 | 309.54 K | $61.54 M | 165.16% | 0.51% |
| TD ASSET MANAGEMENT INC | 11/10/2025 | 296.35 K | $58.92 M | 1.46% | 0.49% |
| JPMORGAN CHASE & CO | 11/26/2025 | 292.40 K | $58.13 M | 40.48% | 0.48% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2025 | 290.17 K | $57.69 M | 44.33% | 0.48% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 238.53 K | $47.42 M | 43.98% | 0.39% |
| SIREN, L.L.C. | 11/13/2025 | 235.86 K | $46.89 M | -4.10% | 0.39% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 11/14/2025 | 234.40 K | $46.60 M | -10.97% | 0.39% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2025 | 214.50 K | $42.64 M | -1.15% | 0.35% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 209.30 K | $41.61 M | 77.95% | 0.35% |
| VICTORY CAPITAL MANAGEMENT INC | 11/12/2025 | 208.93 K | $41.54 M | -4.65% | 0.35% |
| SEI INVESTMENTS CO | 11/13/2025 | 205.32 K | $40.82 M | -13.21% | 0.34% |
| UBS GROUP AG | 11/13/2025 | 195.20 K | $38.81 M | 135.87% | 0.32% |
| ORBIMED ADVISORS LLC | 11/14/2025 | 191.91 K | $38.15 M | 457.86% | 0.32% |
| ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 10/20/2025 | 191.67 K | $39.12 M | -4.29% | 0.32% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 11/07/2025 | 189.65 K | $37.71 M | -31.53% | 0.31% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 183.89 K | $36.56 M | 5,803.24% | 0.30% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 11/14/2025 | 179.17 K | $35.62 M | -8.17% | 0.30% |
| CANDRIAM S.C.A. | 11/06/2025 | 178.96 K | $35.58 M | -8.28% | 0.30% |
| ARS INVESTMENT PARTNERS, LLC | 10/15/2025 | 175.67 K | $34.92 M | -16.32% | 0.29% |
| TRI LOCUM PARTNERS LP | 11/14/2025 | 174.83 K | $34.76 M | 18.41% | 0.29% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 174.60 K | $34.71 M | 139.55% | 0.29% |
| FRED ALGER MANAGEMENT, LLC | 11/14/2025 | 170.70 K | $33.94 M | 4,398.05% | 0.28% |
| Q GLOBAL ADVISORS, LLC | 11/13/2025 | 170.00 K | $33.80 M | -33.33% | 0.28% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Ascendis Pharma A/S institutional Ownership - FAQ's
During the previous two years, 347 institutional investors and hedge funds held shares of Ascendis Pharma A/S. The most heavily invested institutionals were:
RA CAPITAL MANAGEMENT, L.P.: 10.28 M
WESTFIELD CAPITAL MANAGEMENT CO LP: 5.26 M
Avoro Capital Advisors LLC: 5.11 M
FMR LLC: 4.47 M
JANUS HENDERSON GROUP PLC: 4.32 M
Lombard Odier Asset Management (Europe) Ltd: 4.27 M
113.27% of Ascendis Pharma A/S stock is owned by institutional investors.
Institutional investors have bought a total of 71.76 M shares in the last 24 months. This purchase volume represents approximately $14.64 B in transactions.